#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	504	CRP	633	633	99.53	CRP.l15.c4.ctg.1	1209	31.4	0	.	p	.	0	K29T	NONSYN	85	87	AAG	365	367	ACG	36;35;34	A;C;G	36;35;34	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	1	1	528	18	Enterobacter_aerogenes_omp36	1128	116	91.38	Enterobacter_aerogenes_omp36.l6.c4.ctg.1	158	4.8	0	.	p	.	0	G319D	NONSYN	955	957	GGC	3	5	GAC	2;2;3	G;A;C	2;2;3	.	Enterobacter aerogenes omp36 mutants
Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	1	1	528	18	Enterobacter_aerogenes_omp36	1128	116	91.38	Enterobacter_aerogenes_omp36.l6.c4.ctg.1	158	4.8	0	.	p	.	0	Q321E	NONSYN	961	963	CAG	9	11	GAA	4;5;5	G;A;A	4;5;5	.	Enterobacter aerogenes omp36 mutants
Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	1	1	528	18	Enterobacter_aerogenes_omp36	1128	116	91.38	Enterobacter_aerogenes_omp36.l6.c4.ctg.1	158	4.8	0	.	p	.	0	L329V	NONSYN	985	987	CTG	33	35	GTT	6;7;7	G;T;T	6;7;7	.	Enterobacter aerogenes omp36 mutants
Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	Enterobacter_aerogenes_omp36.3003385.AF335467.36_1164.2109	1	1	528	18	Enterobacter_aerogenes_omp36	1128	116	91.38	Enterobacter_aerogenes_omp36.l6.c4.ctg.1	158	4.8	0	.	p	.	0	K354Q	NONSYN	1060	1062	AAG	108	110	CAG	4;4;3	C;A;G	4;4;3	.	Enterobacter aerogenes omp36 mutants
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	155	1788	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1744	73.0	1	SNP	p	R234F	1	.	.	700	702	TTC	938	940	TTC	116;115;115	T;T;C	116;114;114	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	155	1788	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1744	73.0	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1238	1240	CGT	89;90;89	C;G;T	89;90;89	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	155	1788	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1744	73.0	0	HET	.	.	.	T180C	.	180	180	T	418	418	T	90	T,C	50,40	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	155	1788	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1744	73.0	0	HET	.	.	.	T999C	.	999	999	T	1237	1237	T	88	T,C	56,32	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	155	1788	Escherichia_coli_EF_Tu	1230	1230	99.84	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1744	73.0	0	HET	.	.	.	C255T	.	255	255	C	493	493	C	89	C,T	42,47	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	770	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c4.ctg.1	1890	30.4	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1536	1538	AAA	29;29;29	A;A;A	29;29;27	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1020	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c30.ctg.1	1970	38.7	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1335	1337	GAA	42;42;42	G;A;A,T	42;42;41,1	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	256	H_NS	414	414	99.03	H_NS.l15.c4.ctg.1	991	19.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	145	G	144	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	146	C	146	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	153	C	152	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	218	T	218	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	225	C	225	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	200	C,G	199,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	183	A	182	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	182	A	181	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	174	A	173	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	156	T	154	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	155	C	155	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	154	C	154	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	153	A	153	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	157	G	157	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	162	C	161	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	169	T	169	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	171	G	170	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	166	G	166	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	164	T	163	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	198	T	197	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	194	G	194	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	179	C	179	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	177	A	177	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	134	C	134	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	126	C	126	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	95	A	94	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	105	A	104	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	123	G	122	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	107	C	107	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	144	T	144	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	145	G	145	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	134	T	133	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.2	518	173.8	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	245	C	244	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	182	92.86	Pasteurella_multocida_16S.l15.c30.ctg.3	182	37.5	0	.	n	.	0	C990G	SNP	990	990	C	58	58	G	37	G	35	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	182	92.86	Pasteurella_multocida_16S.l15.c30.ctg.3	182	37.5	0	.	n	.	0	T1002A	SNP	1002	1002	T	70	70	A	39	A	39	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	182	92.86	Pasteurella_multocida_16S.l15.c30.ctg.3	182	37.5	0	.	n	.	0	A1004G	SNP	1004	1004	A	72	72	G	40	G	40	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	182	92.86	Pasteurella_multocida_16S.l15.c30.ctg.3	182	37.5	0	.	n	.	0	C1011T	SNP	1011	1011	C	79	79	T	43	T	43	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	182	92.86	Pasteurella_multocida_16S.l15.c30.ctg.3	182	37.5	0	.	n	.	0	C1023A	SNP	1023	1023	C	91	91	A	50	A	50	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	182	92.86	Pasteurella_multocida_16S.l15.c30.ctg.3	182	37.5	0	.	n	.	0	T1024A	SNP	1024	1024	T	92	92	A	52	A	52	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	182	92.86	Pasteurella_multocida_16S.l15.c30.ctg.3	182	37.5	0	.	n	.	0	T1041G	SNP	1041	1041	T	109	109	G	57	G	56	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	182	92.86	Pasteurella_multocida_16S.l15.c30.ctg.3	182	37.5	0	.	n	.	0	A1042T	SNP	1042	1042	A	110	110	T	56	T	55	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	186	92.51	Pasteurella_multocida_16S.l15.c30.ctg.5	186	56.4	0	.	n	.	0	C990G	SNP	990	990	C	62	62	G	41	G	34	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	186	92.51	Pasteurella_multocida_16S.l15.c30.ctg.5	186	56.4	0	.	n	.	0	T1002A	SNP	1002	1002	T	74	74	A	32	A	32	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	186	92.51	Pasteurella_multocida_16S.l15.c30.ctg.5	186	56.4	0	.	n	.	0	A1003C	SNP	1003	1003	A	75	75	C	32	C	32	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	186	92.51	Pasteurella_multocida_16S.l15.c30.ctg.5	186	56.4	0	.	n	.	0	G1008C	SNP	1008	1008	G	80	80	C	33	C	33	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	186	92.51	Pasteurella_multocida_16S.l15.c30.ctg.5	186	56.4	0	.	n	.	0	C1011T	SNP	1011	1011	C	83	83	T	33	T	33	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	186	92.51	Pasteurella_multocida_16S.l15.c30.ctg.5	186	56.4	0	.	n	.	0	T1012C	SNP	1012	1012	T	84	84	C	34	C	34	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	186	92.51	Pasteurella_multocida_16S.l15.c30.ctg.5	186	56.4	0	.	n	.	0	C1023A	SNP	1023	1023	C	94	94	A	45	A	45	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	186	92.51	Pasteurella_multocida_16S.l15.c30.ctg.5	186	56.4	0	.	n	.	0	.1025G	INS	1025	1025	T	97	97	G	46	G	46	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	186	92.51	Pasteurella_multocida_16S.l15.c30.ctg.5	186	56.4	0	.	n	.	0	T1041G	SNP	1041	1041	T	113	113	G	56	G	56	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	2512	Pasteurella_multocida_16S	1551	186	92.51	Pasteurella_multocida_16S.l15.c30.ctg.5	186	56.4	0	.	n	.	0	A1042T	SNP	1042	1042	A	114	114	T	60	T	60	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	780	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1517	38.5	0	.	p	.	0	H2R	NONSYN	4	6	CAT	287	289	CGT	36;38;38	C;G;T	36;37;37	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	780	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1517	38.5	0	.	p	.	0	V30I	NONSYN	88	90	GTC	371	373	ATC	49;47;46	A;T;C	49;47;46	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	780	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1517	38.5	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1130	1132	GGC	51;49;48	G;G;C	50;48;48	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1024	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	2283	33.7	0	.	p	.	0	R8S	NONSYN	22	24	AGA	334	336	AGC	16;17;17	A;G;C	16;17;17	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1024	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	2283	33.7	0	.	p	.	0	I142L	NONSYN	424	426	ATA	736	738	CTA	44;45;44	C;T;A	44;45;43	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1024	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	2283	33.7	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1255	1257	CAA	62;59;60	C;A;A	62;59;59	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1024	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	2283	33.7	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1354	1356	GGT	65;65;66	G;G;T	65;65;66	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1024	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	2283	33.7	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1924	1926	GTT	30;30;29	G;T;T	30;30;29	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	354	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1538	17.4	0	.	p	.	0	A125E	NONSYN	373	375	GCA	592	594	GAA	23;23;23	G;A;A	22;23;22	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	354	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1538	17.4	0	.	p	.	0	M185T	NONSYN	553	555	ATG	772	774	ACC	19;19;19	A;C;C	19;19;19	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	354	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1538	17.4	0	.	p	.	0	S225T	NONSYN	673	675	TCC	892	894	ACT	12;10;10	A;C;T	12;10;10	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	354	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1538	17.4	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1282	1284	ATC	10;10;10	A;T;C	10;10;10	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	620	PmrF	969	969	99.38	PmrF.l15.c30.ctg.1	1616	29.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
TEM_124.3000986.AY327540.0_858.1398	TEM_124.3000986.AY327540.0_858.1398	1	0	528	14	TEM_1+	858	271	99.63	TEM_1+.l15.c30.ctg.1	271	1.7	0	.	p	.	0	T180M	NONSYN	538	540	ACG	88	90	ATG	2;2;2	A;T;G	2;2;2	.	TEM-124 is an extended-spectrum beta-lactamase found in Morganella morganii.;TEM-124
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	531	1760	acrD	3114	3114	99.07	acrD.l15.c30.ctg.1	3600	36.7	0	.	p	.	0	T85I	NONSYN	253	255	ACC	479	481	ATC	45;45;45	A;T;C	45;45;45	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	531	1760	acrD	3114	3114	99.07	acrD.l15.c30.ctg.1	3600	36.7	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2192	2194	AAG	43;42;43	A;A;G	43;42;43	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	531	1760	acrD	3114	3114	99.07	acrD.l15.c30.ctg.1	3600	36.7	0	.	p	.	0	S811trunc	TRUNC	2431	2431	T	2657	2657	T	40	T	40	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	760	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1662	34.0	0	.	p	.	0	A22V	NONSYN	64	66	GCC	252	254	GTC	34;33;33	G;T,G;C	34;32,1;33	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	760	acrE	1158	1158	98.79	acrE.l6.c30.ctg.1	1662	34.0	0	.	p	.	0	S269C	NONSYN	805	807	AGC	993	995	TGC	43;43;44	T;G;C	43;43;44	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1942	acrF	3105	3105	98.71	acrF.l15.c30.ctg.1	3680	39.7	0	.	p	.	0	S46trunc	TRUNC	136	136	T	449	449	T	44	T	44	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1942	acrF	3105	3105	98.71	acrF.l15.c30.ctg.1	3680	39.7	0	.	p	.	0	G148D	NONSYN	442	444	GGC	755	757	GAC	45;44;44	G;A;C	45;43;43	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1942	acrF	3105	3105	98.71	acrF.l15.c30.ctg.1	3680	39.7	0	.	p	.	0	F240L	NONSYN	718	720	TTT	1031	1033	TTA	31;30;29	T;T;A	31;30;29	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1942	acrF	3105	3105	98.71	acrF.l15.c30.ctg.1	3680	39.7	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1214	1216	AAT	42;42;42	A;A;T	42;42;42	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1942	acrF	3105	3105	98.71	acrF.l15.c30.ctg.1	3680	39.7	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	2108	2110	AAT	29;30;29	A;A;T	29;30;29	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1942	acrF	3105	3105	98.71	acrF.l15.c30.ctg.1	3680	39.7	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	2222	2224	AGT	49;49;49	A;G;T	48;48;48	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1942	acrF	3105	3105	98.71	acrF.l15.c30.ctg.1	3680	39.7	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	2621	2623	GTG	43;44;44	G;T;G	43;44;44	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1942	acrF	3105	3105	98.71	acrF.l15.c30.ctg.1	3680	39.7	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	3176	3178	AAG	46;48;48	A;A;G	46;47;47	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	382	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1234	23.2	1	SNP	p	R45C	0	.	.	133	135	CGC	384	386	CGC	28;28;28	C;G;C	27;28;28	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	368	acrS	663	663	98.64	acrS.l15.c30.ctg.1	1295	21.4	0	.	p	.	0	L34F	NONSYN	100	102	CTC	410	412	TTC	26;25;25	T;T;C	26;25;25	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	368	acrS	663	663	98.64	acrS.l15.c30.ctg.1	1295	21.4	0	.	p	.	0	E122G	NONSYN	364	366	GAG	674	676	GGG	32;32;32	G;G;G	32;32;32	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	410	adiY	762	762	99.61	adiY.l15.c4.ctg.1	1244	24.7	0	.	p	.	0	V136L	NONSYN	406	408	GTT	628	630	CTT	38;36;36	C;T;T	38;36;36	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1698	alaS	2631	2631	98.9	alaS.l15.c30.ctg.1	3434	37.2	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2184	2186	GCA	49;47;51	G;C;A	49;47;51	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1698	alaS	2631	2631	98.9	alaS.l15.c30.ctg.1	3434	37.2	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2445	2447	ACC	63;63;62	A;C;C	58;63;62	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1698	alaS	2631	2631	98.9	alaS.l15.c30.ctg.1	3434	37.2	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2754	2756	GCC	57;58;58	G;C;C	56;57;57	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	942	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2498	28.0	0	.	p	.	0	G37A	NONSYN	109	111	GGT	342	344	GCT	27;28;28	G;C;T	26;27;26	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	942	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2498	28.0	0	.	p	.	0	D77E	NONSYN	229	231	GAT	462	464	GAG	20;19;20	G;A;G	20;19;20	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	942	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2498	28.0	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	498	500	TGC	13;13;13	T;G;C	13;13;13	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	942	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2498	28.0	0	.	p	.	0	I150V	NONSYN	448	450	ATT	681	683	GTT	24;25;25	G;T;T	24;24;25	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	942	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2498	28.0	0	.	p	.	0	R200H	NONSYN	598	600	CGC	831	833	CAC	26;26;26	C;A;C	26;25;26	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	942	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2498	28.0	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1116	1118	ATG	43;42;44	A;T;G	43;41;44	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	942	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2498	28.0	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2112	2114	CGC	42;39;39	C;G;C	42;39;39	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	942	arnA_1	1983	1983	98.24	arnA_1.l15.c30.ctg.1	2498	28.0	0	.	p	.	0	L646Q	NONSYN	1936	1938	CTG	2169	2171	CAG	32;33;33	C;A;G	31;32;33	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	448	bacA	822	822	98.54	bacA.l6.c4.ctg.1	1499	22.5	0	.	p	.	0	S221T	NONSYN	661	663	AGC	1023	1025	ACC	21;23;22	A;C;C	20;23;22	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	448	bacA	822	822	98.54	bacA.l6.c4.ctg.1	1499	22.5	0	.	p	.	0	P225S	NONSYN	673	675	CCG	1035	1037	TCG	23;24;25	T;C;G	23;24;24	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	430	baeR	723	723	97.79	baeR.l15.c4.ctg.1	1475	21.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	648	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1969	24.7	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1418	1420	AAA	27;27;26	A;A;A	27;27;26	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	648	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1969	24.7	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1430	1432	GAG	27;27;27	G;A;G	27;27;27	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	648	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1969	24.7	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1436	1438	CAC	28;27;27	C;A;C	28;27;27	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	648	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1969	24.7	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1490	1492	GAG	16;16;16	G;A;G	16;16;16	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	968	cpxA	1374	1374	98.91	cpxA.l15.c4.ctg.1	2074	35.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	514	cpxR	699	699	99.43	cpxR.l15.c30.ctg.1	1397	27.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	432	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1484	21.9	0	.	p	.	0	A146T	NONSYN	436	438	GCT	688	690	ACT	36;36;36	A;C;T	36;35;36	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	626	emrA	1173	1173	98.29	emrA.l15.c4.ctg.1	1757	26.5	0	.	p	.	0	I219V	NONSYN	655	657	ATC	961	963	GTC	42;41;43	G;T;C	39;40;42	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	1002	emrB	1539	1539	99.74	emrB.l15.c4.ctg.1	2274	33.0	0	.	p	.	0	E197K	NONSYN	589	591	GAA	949	951	AAA	55;55;56	A;A;A	55;55;56	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	800	emrD	1191	1191	98.4	emrD.l6.c17.ctg.1	1677	35.5	0	.	p	.	0	G209S	NONSYN	625	627	GGC	877	879	AGC	60;61;59	A;G;C	60;60;59	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	32	emrE_1	333	155	94.84	emrE_1.l15.c4.ctg.1	176	7.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	442	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1666	20.0	0	.	p	.	0	K176R	NONSYN	526	528	AAG	843	845	AGG	14;14;14	A;G;G	14;14;14	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	442	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1666	20.0	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1233	1235	GAC	14;13;13	G;A;C	14;13;13	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	326	emrR	531	531	100.0	emrR.l15.c17.ctg.1	1126	21.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	684	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	2025	25.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	214	evgA	615	615	99.19	evgA.l15.c30.ctg.1	1088	14.6	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	428	430	CTG	28;28;28	C;T;G	28;28;28	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1352	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4150	24.5	0	.	p	.	0	T38I	NONSYN	112	114	ACA	396	398	ATA	19;18;18	A;T;A	19;18;18	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1352	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4150	24.5	0	.	p	.	0	L42V	NONSYN	124	126	CTA	408	410	GTA	16;16;17	G;T;A	16;16;17	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1352	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4150	24.5	0	.	p	.	0	A93T	NONSYN	277	279	GCG	561	563	ACG	22;22;20	A;C;G	22;22;20	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1352	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4150	24.5	0	.	p	.	0	A114E	NONSYN	340	342	GCA	624	626	GAA	16;16;16	G;A;A	16;16;16	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1352	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4150	24.5	0	.	p	.	0	T127A	NONSYN	379	381	ACT	663	665	GCT	22;21;20	G;C;T	22;21;20	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1352	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4150	24.5	0	.	p	.	0	N133D	NONSYN	397	399	AAT	681	683	GAT	18;18;18	G;A;T	18;18;18	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1352	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4150	24.5	0	.	p	.	0	P162S	NONSYN	484	486	CCA	768	770	TCA	22;22;21	T;C;A	22;22;21	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1352	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4150	24.5	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	897	899	CAG	17;16;16	C;A;G	17;16;16	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1352	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4150	24.5	0	.	p	.	0	I251V	NONSYN	751	753	ATT	1035	1037	GTT	14;14;13	G;T;T	14;14;13	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1352	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4150	24.5	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1191	1193	GAT	24;24;24	G;A;T	24;24;24	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1352	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4150	24.5	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1359	1361	AAT	13;13;12	A;A;T	13;13;12	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1352	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4150	24.5	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1380	1382	TTA	10;10;11	T;T;A	10;10;10	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1352	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4150	24.5	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1581	1583	AAA	18;18;18	A;A;A	18;18;18	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1352	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4150	24.5	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2316	2318	CAT	17;18;17	C;A;T	17;18;17	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1352	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4150	24.5	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2370	2372	CAT	22;22;23	C;A;T	22;22;23	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1352	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4150	24.5	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2388	2390	AGA	27;26;26	A;G;A	27;26;26	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1352	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4150	24.5	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2403	2405	AAT	27;28;29	A;A;T	27;28;29	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1352	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4150	24.5	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2550	2552	TCC	30;30;31	T;C;C	30;30;31	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1352	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4150	24.5	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2715	2717	ATT	24;24;25	A;T;T	24;24;25	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1352	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4150	24.5	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2736	2738	GAT	31;30;30	G;A;T	31;30;30	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1352	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4150	24.5	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2850	2852	GTT	35;33;33	G;T;T	35;33;33	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1352	evgS	3594	3594	97.55	evgS.l15.c4.ctg.1	4150	24.5	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3135	3137	CAC	38;38;38	C;A;C	38;38;38	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	528	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1403	28.3	1	SNP	p	P64R	0	.	.	190	192	CCA	506	508	CCA	53;54;53	C;C;A	53;54;49	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	528	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1403	28.3	1	SNP	p	P64L	0	.	.	190	192	CCA	506	508	CCA	53;54;53	C;C;A	53;54;49	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	528	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1403	28.3	1	SNP	p	P64A	0	.	.	190	192	CCA	506	508	CCA	53;54;53	C;C;A	53;54;49	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	528	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1403	28.3	1	SNP	p	P64S	0	.	.	190	192	CCA	506	508	CCA	53;54;53	C;C;A	53;54;49	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	528	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1403	28.3	1	SNP	p	P64H	0	.	.	190	192	CCA	506	508	CCA	53;54;53	C;C;A	53;54;49	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	254	gadE	528	528	100.0	gadE.l15.c30.ctg.1	1144	16.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	88	gadW	729	729	94.34	gadW.l15.c30.ctg.1	810	8.0	0	.	p	.	0	D34E	NONSYN	100	102	GAT	7	9	GAG	3;3;3	G;A;G	1;1;1	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	88	gadW	729	729	94.34	gadW.l15.c30.ctg.1	810	8.0	0	.	p	.	0	L46P	NONSYN	136	138	CTG	43	45	CCG	1;1;1	C;C;G	1;1;1	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	88	gadW	729	729	94.34	gadW.l15.c30.ctg.1	810	8.0	0	.	p	.	0	E54D	NONSYN	160	162	GAA	67	69	GAT	4;4;4	G;A;T	4;4;4	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	88	gadW	729	729	94.34	gadW.l15.c30.ctg.1	810	8.0	0	.	p	.	0	I88M	NONSYN	262	264	ATA	169	171	ATG	3;3;3	A;T;G	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	88	gadW	729	729	94.34	gadW.l15.c30.ctg.1	810	8.0	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	172	174	CCG	3;3;3	C;C;G	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	88	gadW	729	729	94.34	gadW.l15.c30.ctg.1	810	8.0	0	.	p	.	0	D100E	NONSYN	298	300	GAC	205	207	GAA	1;1;1	G;A;A	1;1;1	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	88	gadW	729	729	94.34	gadW.l15.c30.ctg.1	810	8.0	0	.	p	.	0	P101S	NONSYN	301	303	CCC	208	210	TCC	1;1;1	T;C;C	1;1;1	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	88	gadW	729	729	94.34	gadW.l15.c30.ctg.1	810	8.0	0	.	p	.	0	R102G	NONSYN	304	306	CGG	211	213	GGG	1;1;1	G;G;G	1;1;1	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	88	gadW	729	729	94.34	gadW.l15.c30.ctg.1	810	8.0	0	.	p	.	0	K110N	NONSYN	328	330	AAA	235	237	AAT	2;2;2	A;A;T	2;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	539	88	gadW	729	729	94.34	gadW.l15.c30.ctg.1	810	8.0	0	.	p	.	0	S234A	NONSYN	700	702	TCG	607	609	GCG	8;8;8	G;C;G	8;8;8	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	290	gadX	825	825	97.94	gadX.l15.c4.ctg.1	1313	16.7	0	.	p	.	0	F53L	NONSYN	157	159	TTC	391	393	TTA	17;17;16	T;T;A	17;17;16	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	290	gadX	825	825	97.94	gadX.l15.c4.ctg.1	1313	16.7	0	.	p	.	0	V79I	NONSYN	235	237	GTT	469	471	ATT	24;24;24	A;T;T	24;24;24	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	290	gadX	825	825	97.94	gadX.l15.c4.ctg.1	1313	16.7	0	.	p	.	0	R246G	NONSYN	736	738	AGA	970	972	GGA	15;16;18	G;G;A	14;16;16	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	290	gadX	825	825	97.94	gadX.l15.c4.ctg.1	1313	16.7	0	.	p	.	0	S248P	NONSYN	742	744	TCG	976	978	CCG	17;21;21	C;C;G	17;21;20	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1620	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3229	37.5	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2377	2379	GAA	44;46;46	G;A;A	44;46;46	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1620	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3229	37.5	1	SNP	p	S83I	0	.	.	247	249	TCG	592	594	TCG	41;41;41	T;C,T;G	41;40,1;41	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1620	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3229	37.5	1	SNP	p	S83W	0	.	.	247	249	TCG	592	594	TCG	41;41;41	T;C,T;G	41;40,1;41	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1620	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3229	37.5	1	SNP	p	S83L	0	.	.	247	249	TCG	592	594	TCG	41;41;41	T;C,T;G	41;40,1;41	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1620	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3229	37.5	1	SNP	p	D87H	0	.	.	259	261	GAC	604	606	GAC	41;41;42	G;A;C	40;41;42	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1620	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3229	37.5	1	SNP	p	D87Y	0	.	.	259	261	GAC	604	606	GAC	41;41;42	G;A;C	40;41;42	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1620	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3229	37.5	1	SNP	p	D87G	0	.	.	259	261	GAC	604	606	GAC	41;41;42	G;A;C	40;41;42	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1620	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3229	37.5	1	SNP	p	D87N	0	.	.	259	261	GAC	604	606	GAC	41;41;42	G;A;C	40;41;42	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1620	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3229	37.5	1	SNP	p	D87V	0	.	.	259	261	GAC	604	606	GAC	41;41;42	G;A;C	40;41;42	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1426	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	3112	34.5	1	SNP	p	R136G	0	.	.	406	408	CGC	775	777	CGC	42;42;42	C;G;C	41;42;41	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1426	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	3112	34.5	1	SNP	p	R136S	0	.	.	406	408	CGC	775	777	CGC	42;42;42	C;G;C	41;42;41	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1426	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	3112	34.5	1	SNP	p	R136C	0	.	.	406	408	CGC	775	777	CGC	42;42;42	C;G;C	41;42;41	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1426	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	3112	34.5	1	SNP	p	R136H	0	.	.	406	408	CGC	775	777	CGC	42;42;42	C;G;C	41;42;41	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1426	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	3112	34.5	1	SNP	p	R136I	0	.	.	406	408	CGC	775	777	CGC	42;42;42	C;G;C	41;42;41	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1426	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	3112	34.5	1	SNP	p	R136L	0	.	.	406	408	CGC	775	777	CGC	42;42;42	C;G;C	41;42;41	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1426	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	3112	34.5	1	SNP	p	R136E	0	.	.	406	408	CGC	775	777	CGC	42;42;42	C;G;C	41;42;41	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	320	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1213	19.7	0	.	p	.	0	A72P	NONSYN	214	216	GCG	451	453	CCG	32;32;32	C;C;G	32;32;32	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	320	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1213	19.7	0	.	p	.	0	T123A	NONSYN	367	369	ACC	604	606	GCC	26;26;26	G;C;C	26;26;26	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	526	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1512	26.1	0	.	p	.	0	P9S	NONSYN	25	27	CCA	271	273	TCA	24;24;24	T;C;A	24;24;24	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	206	marA	384	384	99.74	marA.l15.c4.ctg.1	937	16.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	208	marR	435	435	97.7	marR.l15.c17.ctg.1	1040	15.1	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	677	679	AGC	27;26;27	A;G;C	27;26;27	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	208	marR	435	435	97.7	marR.l15.c17.ctg.1	1040	15.1	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	779	781	CAT	15;15;15	C;A;T	15;15;15	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	208	marR	435	435	97.7	marR.l15.c17.ctg.1	1040	15.1	1	SNP	p	V45E	0	.	.	133	135	GTG	503	505	GTG	30;30;30	G;T;G	30;30;30	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	208	marR	435	435	97.7	marR.l15.c17.ctg.1	1040	15.1	1	SNP	p	I49S	0	.	.	145	147	ATC	515	517	ATC	36;36;37	A;T;C	36;36;37	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	208	marR	435	435	97.7	marR.l15.c17.ctg.1	1040	15.1	1	SNP	p	A70T	0	.	.	208	210	GCA	578	580	GCA	35;33;34	G;C;A	35;33;34	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	208	marR	435	435	97.7	marR.l15.c17.ctg.1	1040	15.1	1	SNP	p	R73C	0	.	.	217	219	CGT	587	589	CGT	33;33;33	C;G;T	33;33;33	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	208	marR	435	435	97.7	marR.l15.c17.ctg.1	1040	15.1	1	SNP	p	R73S	0	.	.	217	219	CGT	587	589	CGT	33;33;33	C;G;T	33;33;33	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	208	marR	435	435	97.7	marR.l15.c17.ctg.1	1040	15.1	1	SNP	p	R77L	0	.	.	229	231	CGC	599	601	CGC	34;35;35	C;G;C	34;35;35	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	208	marR	435	435	97.7	marR.l15.c17.ctg.1	1040	15.1	1	SNP	p	R77C	0	.	.	229	231	CGC	599	601	CGC	34;35;35	C;G;C	34;35;35	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	208	marR	435	435	97.7	marR.l15.c17.ctg.1	1040	15.1	1	SNP	p	L78M	0	.	.	232	234	CTG	602	604	CTG	35;34;33	C,G;T;G	34,1;34;33	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	208	marR	435	435	97.7	marR.l15.c17.ctg.1	1040	15.1	1	SNP	p	R94H	0	.	.	280	282	CGC	650	652	CGC	36;33;33	C;G;C	36;33;33	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	208	marR	435	435	97.7	marR.l15.c17.ctg.1	1040	15.1	1	SNP	p	R94S	0	.	.	280	282	CGC	650	652	CGC	36;33;33	C;G;C	36;33;33	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	208	marR	435	435	97.7	marR.l15.c17.ctg.1	1040	15.1	1	SNP	p	V96E	0	.	.	286	288	GTA	656	658	GTA	34;34;34	G;T;A	34;34;34	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	564	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1732	24.4	0	.	p	.	0	S7F	NONSYN	19	21	TCC	166	168	TTC	16;16;17	T;T;C	16;16;17	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	564	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1732	24.4	0	.	p	.	0	R36I	NONSYN	106	108	AGG	253	255	ATC	12;12;12	A;T;C	11;12;12	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	564	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1732	24.4	0	.	p	.	0	E42A	NONSYN	124	126	GAA	271	273	GCC	12;13;14	G;C;C	12;13;14	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	564	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1732	24.4	0	.	p	.	0	N43V	NONSYN	127	129	AAT	274	276	GTG	14;14;14	G;T;G	14;14;14	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	564	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1732	24.4	0	.	p	.	0	E52D	NONSYN	154	156	GAG	301	303	GAT	17;17;17	G;A;T	17;17;17	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	564	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1732	24.4	0	.	p	.	0	N59T	NONSYN	175	177	AAC	322	324	ACC	17;18;18	A;C;C	17;18;18	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	564	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1732	24.4	0	.	p	.	0	I68L	NONSYN	202	204	ATA	349	351	TTA	13;13;13	T;T;A	13;13;13	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	564	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1732	24.4	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	490	492	CAG	39;38;38	C;A;G	39;38;38	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	564	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1732	24.4	0	.	p	.	0	D128A	NONSYN	382	384	GAC	529	531	GCC	47;47;46	G;C;C	47;47;46	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	564	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1732	24.4	0	.	p	.	0	S163A	NONSYN	487	489	TCG	634	636	GCG	47;47;47	G;C;G	47;47;47	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	564	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1732	24.4	0	.	p	.	0	L231V	NONSYN	691	693	CTT	838	840	GTT	32;32;32	G;T;T	27;28;32	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	564	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1732	24.4	0	.	p	.	0	R285fs	FSHIFT	853	853	C	1000	1000	C	33	C	33	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	562	mdtA	1248	1248	97.44	mdtA.l15.c30.ctg.1	1805	23.2	0	.	p	.	0	V12trunc	TRUNC	34	34	G	352	352	G	27	G	27	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	562	mdtA	1248	1248	97.44	mdtA.l15.c30.ctg.1	1805	23.2	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	409	411	CAG	23;23;22	C;A;G	23;23;22	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	562	mdtA	1248	1248	97.44	mdtA.l15.c30.ctg.1	1805	23.2	0	.	p	.	0	T83I	NONSYN	247	249	ACC	559	561	ATC	18;18;18	A;T;C	18;18;18	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	562	mdtA	1248	1248	97.44	mdtA.l15.c30.ctg.1	1805	23.2	0	.	p	.	0	I99M	NONSYN	295	297	ATA	607	609	ATG	12;12;13	A;T;G	12;12;13	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	562	mdtA	1248	1248	97.44	mdtA.l15.c30.ctg.1	1805	23.2	0	.	p	.	0	A130T	NONSYN	388	390	GCC	700	702	ACC	22;21;21	A;C;C	22;21;21	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1902	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3738	38.2	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	2080	2082	ACC	36;37;37	A;C;C	36;37;37	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1902	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3738	38.2	0	.	p	.	0	V611I	NONSYN	1831	1833	GTT	2164	2166	ATT	32;31;32	A;T;T	32;30;32	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1902	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3738	38.2	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2473	2475	CAA	45;46;48	C;A;A	44;45;47	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1902	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3738	38.2	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2641	2643	ATT	43;43;42	A;T;T	43;43;41	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1902	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3738	38.2	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2725	2727	GTT	26;26;26	G;T;T,G	26;26;25,1	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1902	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3738	38.2	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2833	2835	GAG	39;39;39	G;A;G	39;38;39	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1902	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3738	38.2	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	3061	3063	ATG	30;30;31	A;T;G	29;30;31	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1902	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3738	38.2	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3196	3198	GAT	43;43;43	G;A;T	43;43;43	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1828	mdtC	3078	3078	98.64	mdtC.l6.c4.ctg.1	3791	36.2	0	.	p	.	0	I46M	NONSYN	136	138	ATC	475	477	ATG	22;21;21	A;T;G	16;21;15	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1828	mdtC	3078	3078	98.64	mdtC.l6.c4.ctg.1	3791	36.2	0	.	p	.	0	V208I	NONSYN	622	624	GTC	961	963	ATC	48;48;47	A;T;C	48;47;47	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1828	mdtC	3078	3078	98.64	mdtC.l6.c4.ctg.1	3791	36.2	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3277	3279	CAC	18;17;16	C;A;C	17;16;16	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1828	mdtC	3078	3078	98.64	mdtC.l6.c4.ctg.1	3791	36.2	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3280	3282	CTC	16;16;16	C;T;C	16;16;15	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	778	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1967	29.6	0	.	p	.	0	D3E	NONSYN	7	9	GAT	237	239	GAA	23;23;23	G;A;A	23;22;23	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	778	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1967	29.6	0	.	p	.	0	T226A	NONSYN	676	678	ACG	906	908	GCG	37;37;37	G;C;G	37;37;37	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	778	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1967	29.6	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1248	1250	ATC	42;42;40	A;T;C	42;41;40	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	778	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1967	29.6	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1551	1553	TTT	40;41;40	T;T;T	40;41;40	.	Efflux pump mdtD;mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	876	mdtE	1158	1158	99.31	mdtE.l15.c30.ctg.1	1907	34.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1910	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3715	38.5	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1146	1148	ACC	29;30;30	A;C;C	29;30;30	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1910	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3715	38.5	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2388	2390	GAC	36;37;38	G;A;C	36;37;38	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	632	mdtG	1227	1047	99.43	mdtG.l15.c30.ctg.1	1671	23.4	0	.	p	.	0	V200I	NONSYN	598	600	GTC	675	677	ATC	28;28;28	A;T;C	28;27;27	.	Efflux protien mdtG.;mdtG
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	632	mdtG	1227	182	99.45	mdtG.l15.c30.ctg.2	666	10.9	0	.	p	.	0	E5G	NONSYN	13	15	GAA	103	105	GGA	8;8;9	G;G;A	8;8;9	.	Efflux protien mdtG.;mdtG
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	684	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1536	33.1	0	.	p	.	0	G134C	NONSYN	400	402	GGT	608	610	TGT	48;48;49	T;G;T	48;48;49	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	684	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1536	33.1	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1178	1180	TTG	34;34;35	T;T;G	33;33;34	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	684	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1536	33.1	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1388	1390	ACG	12;12;12	A;C;G	12;12;12	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	824	mdtL	1176	1176	98.38	mdtL.l15.c30.ctg.1	2078	29.8	0	.	p	.	0	A185S	NONSYN	553	555	GCC	1100	1102	TCC	26;27;26	T;C;C	26;27;26	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	534	mdtN	1032	1032	98.06	mdtN.l15.c30.ctg.1	1595	25.0	0	.	p	.	0	V119I	NONSYN	355	357	GTT	551	553	ATT	36;36;37	A;T;T	36;36;37	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1248	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2684	34.9	0	.	p	.	0	V11M	NONSYN	31	33	GTG	348	350	ATG	33;33;33	A;T;G	33;33;33	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1248	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2684	34.9	0	.	p	.	0	T33I	NONSYN	97	99	ACC	414	416	ATC	17;17;17	A;T;C	17;17;17	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1248	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2684	34.9	0	.	p	.	0	C116R	NONSYN	346	348	TGC	663	665	CGC	35;35;35	C;G,A;C	35;34,1;35	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1248	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2684	34.9	0	.	p	.	0	N238S	NONSYN	712	714	AAC	1029	1031	AGC	37;36;37	A;G;C	37;36;37	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1248	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2684	34.9	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1230	1232	GTG	31;31;31	G;T;G	30;31;31	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1248	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2684	34.9	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1293	1295	AAC	26;27;26	A;A,C;C	23;21,1;26	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1248	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2684	34.9	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1338	1340	GTC	31;30;32	G;T;C	31;30;32	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1248	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2684	34.9	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1368	1370	ATA	31;31;31	A;T;A	31;31;31	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1248	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2684	34.9	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1476	1478	TCT	46;46;47	T;C;T	45;45;47	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1248	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2684	34.9	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1863	1865	GCG	49;49;49	G;C;G	49;49;49	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1248	mdtO	2052	2052	98.1	mdtO.l15.c30.ctg.1	2684	34.9	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	2076	2078	ATC	52;52;53	A;T;C	52;52;53	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	732	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2063	26.7	0	.	p	.	0	S129A	NONSYN	385	387	TCA	693	695	GCG	43;43;41	G;C;G	43;43;41	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	732	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2063	26.7	0	.	p	.	0	A187T	NONSYN	559	561	GCC	867	869	ACC	37;37;37	A;C;C	37;37;37	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	732	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2063	26.7	0	.	p	.	0	H211R	NONSYN	631	633	CAC	939	941	CGC	41;40;39	C;G;C	41;40;39	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	732	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2063	26.7	0	.	p	.	0	V250A	NONSYN	748	750	GTT	1056	1058	GCT	32;32;31	G,A;C;T	31,1;32;31	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	732	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2063	26.7	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1140	1142	AAA	26;26;25	A;A;A	26;26;25	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	732	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2063	26.7	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1158	1160	CGA	22;22;21	C;G;A	22;21;20	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	732	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2063	26.7	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1323	1325	GCC	29;29;28	G;C;C	29;29;28	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	732	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2063	26.7	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1335	1337	GAT	29;29;29	G;A;T	29;29;29	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	732	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	2063	26.7	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1752	1754	GCT	18;18;17	G;C;T	18;17;17	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1972	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	4081	36.3	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1565	1567	AAG	33;32;32	A;A;G	33;32;32	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1972	mfd	3447	3447	99.16	mfd.l15.c4.ctg.1	4081	36.3	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2642	2644	CTG	50;50;50	C;T;G	50;50;50	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	176	mgrB	144	144	100.0	mgrB.l15.c30.ctg.1	603	21.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1166	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2443	35.9	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1180	1182	AAC	35;35;36	A;A;C	34;35;36	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1166	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2443	35.9	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1726	1728	ATA	56;57;57	A;T;A	56;57;57	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	904	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	2012	33.7	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1438	1440	GAT	44;44;45	G;A;T	44;44;45	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	904	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	2012	33.7	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1441	1443	CTG	46;47;47	C;T;G	46;47;47	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	404	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1298	23.2	0	.	p	.	0	R27C	NONSYN	79	81	CGT	285	287	TGT	45;44;43	T;G;T	44;44;43	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	404	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1298	23.2	0	.	p	.	0	I117T	NONSYN	349	351	ATC	555	557	ACC	38;35;36	A;C;C	37;35;36	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	404	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1298	23.2	0	.	p	.	0	G187D	NONSYN	559	561	GGC	765	767	GAC	32;33;31	G;A;C	32;33;31	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	404	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1298	23.2	1	SNP	p	R15C	0	.	.	43	45	CGC	249	251	CGC	46;44;43	C;G;C	46;44;42	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	404	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1298	23.2	1	SNP	p	S33R	0	.	.	97	99	AGC	303	305	AGC	44;43;43	A;G;C	44;43;43	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	404	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1298	23.2	1	SNP	p	G131D	0	.	.	391	393	GGC	597	599	GGC	31;31;31	G;G;C	31;31;31	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	404	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1298	23.2	1	SNP	p	R203C	0	.	.	607	609	CGT	813	815	CGT	36;34;35	C;G;T,G	36;32;34,1	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	404	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	1298	23.2	1	SNP	p	R203L	0	.	.	607	609	CGT	813	815	CGT	36;34;35	C;G;T,G	36;32;34,1	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	676	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1650	30.6	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1219	1221	GAG	42;42;43	G;A;G	42;42;43	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	676	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1650	30.6	1	SNP	p	G141D	0	.	.	421	423	GGT	706	708	GGT	42;44;43	G,A;G,A;T,A	41,1;43,1;42,1	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	676	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1650	30.6	1	SNP	p	G141E	0	.	.	421	423	GGT	706	708	GGT	42;44;43	G,A;G,A;T,A	41,1;43,1;42,1	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	676	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1650	30.6	1	SNP	p	R154D	0	.	.	460	462	CGT	745	747	CGT	48;48;48	C;G;T	48;48;47	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	676	ompF	1089	1089	99.91	ompF.l6.c4.ctg.1	1650	30.6	1	SNP	p	R154A	0	.	.	460	462	CGT	745	747	CGT	48;48;48	C;G;T	48;48;47	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1466	parC_2	2259	2259	99.25	parC_2.l15.c30.ctg.1	2999	36.7	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1933	1935	GTG	42;42;42	G;T;G	41;42;41	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1466	parC_2	2259	2259	99.25	parC_2.l15.c30.ctg.1	2999	36.7	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1960	1962	TCG	50;50;54	T;C;G	48;50;54	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1466	parC_2	2259	2259	99.25	parC_2.l15.c30.ctg.1	2999	36.7	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2575	2577	AAC	27;27;26	A;A;C	27;27;26	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1466	parC_2	2259	2259	99.25	parC_2.l15.c30.ctg.1	2999	36.7	1	SNP	p	A85T	0	.	.	253	255	GCG	589	591	GCG	50;52;50	G;C;G	50;51;50	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1466	parC_2	2259	2259	99.25	parC_2.l15.c30.ctg.1	2999	36.7	1	SNP	p	D111H	0	.	.	331	333	GAT	667	669	GAT	39;43;45	G;A;T	39;43;43	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1466	parC_2	2259	2259	99.25	parC_2.l15.c30.ctg.1	2999	36.7	1	SNP	p	S129P	0	.	.	385	387	TCC	721	723	TCC	46;47;47	T;C;C	46;47;47	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1096	parE_1	1893	1893	97.52	parE_1.l15.c4.ctg.1	2611	31.6	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1694	1696	AAC	44;43;42	A;A;C	44;43;42	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1096	parE_1	1893	1893	97.52	parE_1.l15.c4.ctg.1	2611	31.6	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1703	1705	GAT	45;45;45	G;A;T	45;45;45	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	990	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1976	37.5	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	828	830	CAG	60;58;58	C;A;G	60;58;58	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	990	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1976	37.5	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1302	1304	GAT	43;43;43	G;A;T	43;43;43	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2458	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4655	39.7	1	SNP	p	V146F	0	.	.	436	438	GTT	742	744	GTT	42;40;39	G;T;T	42;40;39	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2458	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4655	39.7	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1843	1845	CAG	43;41;41	C;A;G	43;41;40	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2458	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4655	39.7	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1843	1845	CAG	43;41;41	C;A;G	43;41;40	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2458	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4655	39.7	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1882	1884	CAC	41;40;40	C;A;C	40;39;40	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2458	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4655	39.7	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1891	1893	CGT	35;34;34	C,A;G;T	34,1;34;34	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2458	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4655	39.7	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1891	1893	CGT	35;34;34	C,A;G;T	34,1;34;34	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2458	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4655	39.7	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1897	1899	TCC	31;30;29	T;C;C	30;30;29	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2458	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4655	39.7	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1903	1905	CTC	29;31;31	C;T;C	29;30;31	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2458	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4655	39.7	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1993	1995	ACC	35;35;36	A;C;C	34;34;35	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2458	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4655	39.7	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1996	1998	CCT	34;34;35	C;C;T	33;33;34	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2458	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4655	39.7	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2365	2367	CGT	52;51;51	C;G;T	52;51;51	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8272	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.1	1045	351.9	0	.	n	.	0	A226G	SNP	226	226	A	271	271	G	415	G	412	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8272	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.1	1045	351.9	1	SNP	n	A794T	0	.	.	794	794	A	839	839	A	350	A	347	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8272	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.1	1045	351.9	1	SNP	n	A794G	0	.	.	794	794	A	839	839	A	350	A	347	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8272	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.1	1045	351.9	1	SNP	n	G926C	0	.	.	926	926	G	971	971	G	319	G	318	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8272	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.1	1045	351.9	1	SNP	n	G926T	0	.	.	926	926	G	971	971	G	319	G	318	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8272	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.1	1045	351.9	1	SNP	n	G926A	0	.	.	926	926	G	971	971	G	319	G	318	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8272	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.1	1045	351.9	0	HET	.	.	.	C183T	.	183	183	C	228	228	C	370	C,T	288,80	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8272	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.1	1045	351.9	0	HET	.	.	.	A250T	.	250	250	A	295	295	A	377	A,T	273,100	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8272	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.1	1045	351.9	0	HET	.	.	.	T90C	.	90	90	T	135	135	T	357	T,C	257,97	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8272	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.1	1045	351.9	0	HET	.	.	.	G474A	.	474	474	G	519	519	G	357	G,A	270,85	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8272	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.1	1045	351.9	0	HET	.	.	.	A253T	.	253	253	A	298	298	A	376	A,T	272,99	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8272	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.1	1045	351.9	0	HET	.	.	.	C194T	.	194	194	C	239	239	C	369	C,T	291,75	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8272	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.1	1045	351.9	0	HET	.	.	.	A79G	.	79	79	A	124	124	A	372	A,G	266,105	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8272	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.1	1045	351.9	0	HET	.	.	.	T273A	.	273	273	T	318	318	T	369	T,A	261,107	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8272	rrsB+	1542	1000	99.9	rrsB+.l15.c30.ctg.1	1045	351.9	0	HET	.	.	.	C719T	.	719	719	C	764	764	C	370	C,T	222,145	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8272	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.2	518	310.8	1	SNP	n	A1519C	0	.	.	1519	1519	A	481	481	A	196	A,C	191,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8272	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.2	518	310.8	1	SNP	n	A1519G	0	.	.	1519	1519	A	481	481	A	196	A,C	191,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8272	rrsB+	1542	504	100.0	rrsB+.l15.c30.ctg.2	518	310.8	1	SNP	n	A1519T	0	.	.	1519	1519	A	481	481	A	196	A,C	191,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8272	rrsB+	1542	182	96.17	rrsB+.l15.c30.ctg.4	182	64.2	0	.	n	.	0	G1002A	SNP	1002	1002	G	75	75	A	92	A	92	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8272	rrsB+	1542	182	96.17	rrsB+.l15.c30.ctg.4	182	64.2	0	.	n	.	0	G1006C	SNP	1006	1006	G	79	79	C	94	C	93	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8272	rrsB+	1542	182	96.17	rrsB+.l15.c30.ctg.4	182	64.2	0	.	n	.	0	T1010C	SNP	1010	1010	T	83	83	C	89	C	89	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8272	rrsB+	1542	182	96.17	rrsB+.l15.c30.ctg.4	182	64.2	0	.	n	.	0	A1019.	DEL	1019	1019	A	91	91	G	89	G	89	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8272	rrsB+	1542	182	96.17	rrsB+.l15.c30.ctg.4	182	64.2	0	.	n	.	0	.1023G	INS	1023	1023	T	96	96	G	94	G	94	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8272	rrsB+	1542	182	96.17	rrsB+.l15.c30.ctg.4	182	64.2	0	.	n	.	0	C1038T	SNP	1038	1038	C	111	111	T	95	T	95	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	8272	rrsB+	1542	187	100.0	rrsB+.l15.c30.ctg.5	187	94.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	480	soxR	465	465	100.0	soxR.l15.c4.ctg.1	1212	29.8	1	SNP	p	R20H	0	.	.	58	60	CGC	466	468	CGC	72;71;72	C;G;C	72;71;72	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	480	soxR	465	465	100.0	soxR.l15.c4.ctg.1	1212	29.8	1	SNP	p	G121D	0	.	.	361	363	GGT	769	771	GGT	41;40;40	G;G;T	41;40;40	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	539	264	soxS_1	324	324	99.38	soxS_1.l6.c30.ctg.1	1116	17.8	0	.	p	.	0	V83I	NONSYN	247	249	GTC	704	706	ATC	41;42;43	A;T;C	41;41;43	.	Escherichia coli soxS mutant
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	539	264	soxS_1	324	324	99.38	soxS_1.l6.c30.ctg.1	1116	17.8	1	SNP	p	A12S	0	.	.	34	36	GCA	491	493	GCA	44;45;45	G;C;A	44;45;45	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	539	940	tolC	1488	1488	98.66	tolC.l15.c4.ctg.1	2121	33.3	0	.	p	.	0	A294T	NONSYN	880	882	GCT	1215	1217	ACT	31;31;32	A;C;T	31;31;32	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
